Creating a collaborative database for gastric cancer using AI technology

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This project aims to build and utilize a collaborative network database focused on gastric cancer in Hebei Province, utilizing artificial intelligence technology. It will integrate clinical data, genomic information, and treatment outcomes from various hospitals and research centers in the region. By employing advanced AI algorithms, the database will enable comprehensive data analysis to discover new biomarkers, enhance treatment strategies, and improve patient outcomes. Additionally, it will promote real-time data sharing and collaboration among healthcare providers, researchers, and policymakers to better manage gastric cancer.

Why it matters

Who can join: the full rules

Inclusion Criteria:

All patients with gastric cancer

Exclusion Criteria:

None

Where it's running

• Department of General Surgery
  Shijiazhuang, Hebei, China Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• AI-powered tumor response assessment after preoperative treatment in stomach and gastroesophageal junction cancer

  Researchers are testing whether an AI tool called DeepTRG can reliably measure how much cancer remains in tissue removed after preoperative therapy in stomach and GEJ cancer, without needing a human to correct the AI results.

  Recruiting Hebei Medical University · Shijiazhuang, None Selected · NCT07849608

• AI-based prediction of who will respond to pre-surgery immunotherapy in locally advanced gastric cancer

  A real-world study will test whether an AI system can predict which patients with locally advanced gastric cancer will respond to neoadjuvant chemotherapy plus PD-1 inhibitors before surgery.

  Recruiting at 9 sites Hebei Medical University · Fuyang, Anhui and 8 other locations · NCT07401199

• DeepComp: AI prediction of complications after stomach cancer surgery

  This project will try an AI tool called DeepComp to predict which adults with gastric adenocarcinoma scheduled for curative stomach surgery are at high risk of moderate-to-severe postoperative complications using routine preoperative CT scans and clinical data.

  Recruiting Hebei Medical University · Shijiazhuang, None Selected · NCT07401173

• AI tool to predict lymph node spread and support doctors' decisions in early (T1) stomach cancer

  This study will test whether an AI that combines clinical information, pathology slides, and CT scans can predict lymph node spread in adults with T1 gastric cancer and help doctors of different experience levels make better treatment decisions.

  Recruiting Hebei Medical University · Shijiazhuang, None Selected · NCT07124754

• Using AI to identify lymph node metastasis in gastric cancer

  This study is testing a new AI tool to see if it can better identify lymph node spread in people with gastric cancer compared to regular diagnostic methods.

  Recruiting Hebei Medical University · Shijiazhuang, Hebei · NCT06534814

• Understanding brain changes in patients with neurotoxicity from CAR T-cell therapy

  This study is trying to understand how CAR T-cell therapy affects the brain in patients who develop neurotoxicity, by looking at brain scans and certain chemicals in their spinal fluid.

  Recruiting Hebei Medical University · Shijiazhuang, Hebei · NCT05643092

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.